CLASS I ONGOING Device recall · Reported 15 May 2024 · FDA Enforcement Report

t:connect mobile app used in conjunction recalled

Tandem Diabetes Care is recalling t:connect mobile app used in conjunction with t:slim X2 insulin pump with Control-IQ, distributed nationwide in the US. The recall was initiated on 5 Mar 2024 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesversion 2.7 or later /UDI: 00850006613274
Quantity recalled85,863 applications

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1609-2024
FDA event ID
94312
Recalling firm
Tandem Diabetes Care, San Diego, CA
Classification
Class I
Status
Ongoing
Recall initiated
5 Mar 2024
FDA classified
6 May 2024
Reported
15 May 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

5 Mar 2024Recall initiated by company
6 May 2024Classified by FDA+62 days
15 May 2024Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

During normal use, the mobile app version 2.7 may crash and be automatically relaunched by the iOS operating system. This cycle intermittently repeats, which leads to excessive Bluetooth communication that may result in pump battery drain and may lead to the pump shutting down sooner than typically expected. Pump shutdown will cause insulin delivery to suspend, which could lead to an under-delivery of insulin and may result in hyperglycemia, including severe hyperglycemia.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

t:connect mobile app used in conjunction with t:slim X2 insulin pump with Control-IQ technology

Where it was distributed

US nationwide distribution including Puerto Rico.

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

During normal use, the mobile app version 2.7 may crash and be automatically relaunched by the iOS operating system. This cycle intermittently repeats, which leads to excessive Bluetooth communication that may result in pump battery drain and may lead to the pump shutting down sooner than typically expected. Pump shutdown will cause insulin delivery to suspend, which could lead to an under-delivery of insulin and may result in hyperglycemia, including severe hyperglycemia.

Which lots are affected?

version 2.7 or later /UDI: 00850006613274

Where was it sold?

US nationwide distribution including Puerto Rico.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Tandem Diabetes Care

All 13

Other Insulin Pumps & Glucose Monitors recalls

All 468